Psychotic symptoms in Parkinson’s disease: pathophysiology and management

Author： Bosboom JLW   Wolters ECh  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.3, Iss.3, 2004-05, pp. : 209-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quetiapine: A Review of its Clinical Potential in the Management of Psychotic Symptoms in Parkinson's Disease

By Matheson A.J.   Lamb H.M.  

CNS Drugs, Vol. 14, Iss. 2, 2000-08 ,pp. : 157-172

Adis International

Access to resources Recommend Favorite

Entacapone in the management of Parkinson’s disease

By Waters Cheryl   Henchcliffe Claire  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 957-963

Informa Healthcare

Access to resources Recommend Favorite

Gastrointestinal Motility Problems in Patients with Parkinson’s Disease: Epidemiology, Pathophysiology and Guidelines for Management

By Pfeiffer R.F.  

CNS Drugs, Vol. 11, Iss. 6, 1999-06 ,pp. : 435-448

Adis International

Access to resources Recommend Favorite

Drug treatment of non-motor symptoms in Parkinson’s disease

By Müller Thomas  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. : 381-388

Informa Healthcare

Access to resources Recommend Favorite

Oxcarbazepine: Psychotic symptoms in an elderly patient with Parkinson's disease: case report

By  

Reactions Weekly, Vol. 1, Iss. 1199, 2008-01 ,pp. : 35-36

Adis International

Access to resources Recommend Favorite